SOURCE: IDenta Corp.

March 02, 2010 14:30 ET

International Drug & Explosives Detection Firm IDenta Corp. Reports on US Army Bid for Explosive Identifiers for Afghanistan

JERUSALEM--(Marketwire - March 2, 2010) -  IDenta Corp. (PINKSHEETS: IDTA) CEO Yaacov Shoham reported today that the bid for nitrate test kits (100000 kits) for Afghanistan can be seen at the following link:

https://www.fbo.gov/index?&s=opportunity&mode=form&id=e72982bbb0ce41f518c4b91dc55364b9&tab=core&tabmode=list

The description of products to be used fit only Identa products and the initial specifications of February 26 show that they are requesting Identa kits.

The next PR will be released when the order is finalized and shipment is expected to commence soon thereafter and to be completed within three months.

Information concerning IDenta's entire product line may be found at www.IDenta.biz

ABOUT IDENTA

Since 2003, IDenta Corporation has been recognized as a worldwide leader in the development of proprietary on-site drug, drug precursor and explosive detection kits. IDenta develops, manufactures and distributes products for both the professional and civil markets which consistently pass the highest qualifications and testing procedures of law enforcement and security agencies around the world.

DISCLAIMER

Certain of the statements contained herein may be, within the meaning of the federal securities laws, "forward-looking statements" that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management's expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.

For Investor Relations, lobbying interests or information concerning IDenta's products internationally or the development of new chemical detectors, contact: Yaacov Shoham, IDenta Corp., CEO, Tel: +972-52-6554487, fpi@drugsdetector.com, www.identa.biz.

For information about the Accutest® - IDenta products in the US, please contact: Mr. Eyal Golan, Manager, Business Development, JANT PHARMACAL CORPORATION, 16255 Ventura Blvd. #505, Encino, CA 91436, Toll Free: 800-676-5565, 661-478-0582 (mobile), golan@accutest.net, www.accutestidenta.net.

Contact Information